Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity

5 months ago 17
Read Entire Article
  1. Homepage
  2. Finance
  3. Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity

Related

Tesla launches Model Y L in China from around $47,200

Tesla launches Model Y L in China from around $47,200

59 minutes ago 0
Earnings call transcript: FMC Q2 2025 beats EPS estimates, stock dips

Earnings call transcript: FMC Q2 2025 beats EPS estimates, s...

59 minutes ago 0
US charity says halt in visitor visas for Gazans will harm wounded kids

US charity says halt in visitor visas for Gazans will harm w...

59 minutes ago 0

Trending

1. rey mysterio
2. speed
3. nestor cortes
4. john williams
5. jimmy uso
6. chicago stars vs seattle reign fc
7. centerpoint energy
8. sam hartman commanders
9. natalya wwe
10. natalya neidhart

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

6 months ago 463
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 226
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 192
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 169
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

5 months ago 165
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved